¾î¶»°Ô ³ú¸¦ °íÄ¥ °ÍÀΰ¡ ¾ËÃ÷ÇÏÀÌ¸Ó º´ ½Å¾à°³¹ßÀ» Áß½ÉÀ¸·Î
±è¼º¹Î Àú | ¹ÙÀÌ¿À½ºÆåÅ×ÀÌÅÍ
¡ØÃ¥¼Ò°³
»ý¸í°úÇÐÀº ¾ËÃ÷ÇÏÀÌ¸Ó º´À» Ä¡·áÇÏ´Â ½Å¾àÀ» °³¹ßÇÒ ¼ö ÀÖÀ»±î? ½Å°æ»ý¸®ÇÐÀ» ¿¬±¸ÇÏ´ø °úÇÐ ±âÀÚ°¡ ã¾Æ´Ù´Ñ ÅðÇ༺ ³úÁúȯ, ƯÈ÷ ¾ËÃ÷ÇÏÀÌ¸Ó º´ Ä¡·áÁ¦ °³¹ß À̾߱â. 300¿© ÆíÀÇ ³í¹®°ú ÀÓ»ó½ÃÇè Á¤º¸, Àü ¼¼°èÀû ±Ô¸ðÀÇ ÃÊ´ëÇü Á¦¾à±â¾÷ºÎÅÍ Çõ½ÅÀûÀÎ ¾ÆÀ̵ð¾î·Î ½ÃÀÛÇÏ´Â ¹ÙÀÌ¿ÀÅ×Å©±îÁö 60¿© °÷ÀÇ °³¹ßÀü·«À» ¹ÙÅÁÀ¸·Î ¾ËÃ÷ÇÏÀÌ¸Ó º´ ½Å¾à°³¹ßÀÇ ¿À´ÃÀ» »ìÆ캸°í, ³»ÀÏÀ» Àü¸ÁÇÑ´Ù.
¡Ø¸ñÂ÷
¸Ó¸®¸» 005
¾Æ¹Ð·ÎÀÌµå °¡¼³ Amyloid Cascade Hypothesis 017
¾ÆµÎÄ«´©¸¿ Aducanumab 039
Á¶±âÁø´Ü Early Diagnosis 055
¹ÙÀÌ¿À¸¶Ä¿ Biomarker 083
¾çÀüÀÚ ¹æÃâ ´ÜÃþ ÃÔ¿µ Positron Emission Tomography, PET 115
Ÿ¿ì Tau 143
ÀÌÁßÇ×ü Bispecific Antibody 199
½Å°æ¸é¿ª Neuroimmunology 233
Æ®·½2 TREM2 271
Àü·« Strategy 293
ÃëÀç ¸Þ¸ð 331
¸ÎÀ½¸» 369
ã¾Æº¸±â 378
ºÎ·Ï 407
Mini-Mental State Examination-Korean (MMSE-K)
Clinical Dementia Rating Scale Sum of Boxes Scores (CDR-SB)